Citation: Gs. Mattu et al., Comparison of the oscillometric blood pressure monitor (BIRM-100(beta)) with the auscultatory mercury sphygmomanometer, BL PRESS M, 6(3), 2001, pp. 153-159
Authors:
Wright, JM
Mattu, GS
Perry, TL
Gelfer, ME
Strange, KD
Zorn, A
Chen, YQ
Citation: Jm. Wright et al., Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor, BL PRESS M, 6(3), 2001, pp. 161-165
Authors:
McAlister, FA
Levine, M
Zarnke, KB
Campbell, N
Lewanczuk, R
Leenen, F
Rabkin, S
Wright, JM
Stone, J
Feldman, RD
Lebel, M
Honos, G
Fodor, G
Burgess, E
Tobe, S
Hamet, P
Herman, R
Irvine, J
Culleton, B
Petrella, R
Touyz, R
Citation: Fa. Mcalister et al., The 2000 Canadian recommendations for the management of hypertension: Partone - therapy, CAN J CARD, 17(5), 2001, pp. 543-559
Citation: Jm. Wright, The value of industry-sponsored studies of initial antihypertensive therapies - Response, CAN MED A J, 164(13), 2001, pp. 1832-1833
Citation: P. Liesi et al., Biologically active sequence (KDI) mediates the neurite outgrowth functionof the gamma-1 chain of laminin-1, J NEUROSC R, 66(6), 2001, pp. 1047-1053
Citation: Rr. Throndson et al., Atypical histiocytic granuloma of the oral mucosa: An unusual clinicopathologic entity simulating malignancy, J ORAL MAX, 59(7), 2001, pp. 822-826
Authors:
Wright, JM
Pellicci, PM
Salvati, EA
Ghelman, B
Roberts, MM
Koh, JL
Citation: Jm. Wright et al., Bone density adjacent to press-fit acetabular components - A prospective analysis with quantitative computed tomography, J BONE-AM V, 83A(4), 2001, pp. 529-536
Citation: Re. Alexander et al., Evaluating, documenting and following up oral pathological conditions - A suggested protocol, J AM DENT A, 132(3), 2001, pp. 329-335
Citation: Gb. Jones et al., Understanding enediyne-protein interactions: Diyl atom transfer results ingeneration of aminoacyl radicals, ORG LETT, 2(6), 2000, pp. 811-813
Authors:
Jones, GB
Wright, JM
Hynd, G
Wyatt, JK
Yancisin, M
Brown, MA
Citation: Gb. Jones et al., Protein-degrading enediynes: Library screening of Bergman cycloaromatization products, ORG LETT, 2(13), 2000, pp. 1863-1866
Citation: Jm. Wright, Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 3: Angiotensin-converting-enzyme inhibitors, CAN MED A J, 163(3), 2000, pp. 293-296
Citation: Jm. Wright, Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2: beta-blockers, CAN MED A J, 163(2), 2000, pp. 188-192
Citation: Jm. Wright, Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics, CAN MED A J, 163(1), 2000, pp. 57-60